Drawing for AZAD

USPTO serial 79031580

AZAD

Reviewed by CopyMark Law Group

Reg. 3411804Status 404
Filing date
Status date
Registration date
Apr 15, 2008
Examiner
BESCH, JAY C
Law office
PUBLICATION AND ISSUE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with AZAD?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Stacey R. Halpern

STACEY R. HALPERN KNOBBE, MARTENS, OLSON & BEAR, LLP2040 MAIN STREET14TH FLOORIRVINE, CA 92614

Goods and services

ClassDescriptionStatusFirst use
005PHARMACEUTICAL PRODUCTS, NAMELY, PHARMACEUTICAL PRODUCTS AND PREPARATIONS FOR THE TREATMENT OF CANCER, OPHTHALMIC, CARDIOVASCULAR, NEUROLOGICAL, RESPIRATORY, DIGESTIVE AND INFLAMMATORY DISEASE; VETERINARY PRODUCTS, NAMELY, VETERINARY PREPARATIONS FOR THE TREATMENT OF CANCER, OPHTHALMIC, CARDIOVASCULAR, NEUROLOGICAL, RESPIRATORY, DIGESTIVE AND INFLAMMATORY DISEASE; SANITARY PREPARATIONS FOR MEDICAL PURPOSES; DIETETIC FOODS ADAPTED FOR MEDICAL USE; ADJUVANTS FOR MEDICAL PURPOSES, NAMELY, RECOMBINANT PROTEINS AND VACCINES FOR HUMAN AND VETERINARY USE; AMINO ACIDS FOR MEDICAL PURPOSES; ANESTHETICS, NAMELY ANESTHETICS FOR SURGICAL AND NON-SURGICAL USE; ANALGESICS; VERMIFUGES; ANTIBIOTICS; BIOLOGICAL PREPARATIONS FOR MEDICAL PURPOSES, NAMELY BIOLOGICAL PREPARATIONS TO PRODUCE MEDICINES FOR HUMAN OR VETERINARY USE; CHEMICAL PREPARATIONS FOR PHARMACEUTICAL PURPOSES, NAMELY, BISMUTH PREPARATIONS FOR PHARMACEUTICAL PURPOSES, POTASSIUM PREPARATIONS FOR PHARMACEUTICAL PURPOSES; CHEMICAL REAGENTS FOR MEDICAL OR VETERINARY PURPOSES; CHEMICAL-PHARMACEUTICAL PREPARATIONS, NAMELY, CHEMICAL PREPARATIONS FOR SANITARY USE, PHARMACEUTICAL PREPARATIONS FOR USE IN CHEMOTHERAPY; FERMENTS FOR MEDICAL OR VETERINARY USE; HORMONES FOR MEDICAL PURPOSES; MEDICAL INFUSIONS IN THE NATURE OF PLANT EXTRACTS FOR MEDICAL AND VETERINARY PURPOSES; MEDICINES FOR DENTAL PURPOSES, NAMELY TOPICAL AND SURGICAL ANESTHETICS; MEDICINES FOR HUMAN PURPOSES, NAMELY, MEDICINES FOR THE TREATMENT OF CANCER, OPHTHALMIC, CARDIOVASCULAR, NEUROLOGICAL, RESPIRATORY, DIGESTIVE AND INFLAMMATORY DISEASE; PHARMACEUTICAL PREPARATIONS, NAMELY, FOR THE TREATMENT OF CANCER, OPHTHALMIC, CARDIOVASCULAR, NEUROLOGICAL, RESPIRATORY, DIGESTIVE AND INFLAMMATORY DISEASE; PILLS FOR PHARMACEUTICAL PURPOSES, NAMELY, PILLS CONTAINING PHARMACEUTICAL PRODUCTS AND PREPARATIONS FOR THE TREATMENT OF CANCER, OPHTHALMIC, CARDIOVASCULAR, NEUROLOGICAL, RESPIRATORY, DIGESTIVE AND INFLAMMATORY DISEASE; RADIOLOGICAL CONTRAST MEDIA FOR MEDICAL PURPOSES; STEROIDSSECTION 71 - CANCELLED—
042SCIENTIFIC AND TECHNOLOGICAL SERVICES, NAMELY, SCIENTIFIC RESEARCH, TECHNOLOGY CONSULTATION AND RESEARCH, ALL IN THE FIELD OF CHEMICO-PHARMACEUTICAL PREPARATIONS; INDUSTRIAL ANALYSIS AND RESEARCH SERVICES IN THE FIELD OF CHEMICO-PHARMACEUTICAL PREPARATIONS; LEGAL SERVICES; BIOLOGICAL RESEARCH; CHEMICAL ANALYSIS; CHEMICAL RESEARCH; CHEMISTRY SERVICES, NAMELY CHEMISTRY CONSULTATION, RESEARCH IN THE FIELD OF CHEMISTRY; QUALITY CONTROL FOR OTHERS IN THE FIELD OF HUMAN AND VETERINARY PHARMACEUTICAL PREPARATIONS; INTELLECTUAL PROPERTY CONSULTANCY; LICENSING OF INTELLECTUAL PROPERTY; QUALITY CONTROL FOR OTHERS; RESEARCH AND DEVELOPMENT OF NEW PRODUCTS FOR THIRD PARTIESSECTION 71 - CANCELLED—
044MEDICAL SERVICES, VETERINARY SERVICESSECTION 71 - CANCELLED—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Sep 20, 2018DENCNOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG MAILED—
Sep 20, 2018DETHDEATH OF INTERNATIONAL REGISTRATION—
May 26, 2016NREPNEW REPRESENTATIVE AT IB RECEIVED—
Sep 24, 2015INNTTOTAL INVALIDATION PROCESSED BY THE IB—
Sep 1, 2015INTSTOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB—
Sep 1, 2015INPCINVALIDATION PROCESSED—
Aug 5, 2015INTRTOTAL INVALIDATION OF REG EXT PROTECTION CREATED—
Jan 3, 2015ADCHCHANGE OF NAME/ADDRESS REC'D FROM IB—
Dec 5, 2014C71TCANCELLED SECTION 71—
Apr 14, 2013FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
Mar 26, 2012ADCHCHANGE OF NAME/ADDRESS REC'D FROM IB—
Jul 18, 2009NREPNEW REPRESENTATIVE AT IB RECEIVED—
Jul 31, 2008FICSFINAL DISPOSITION NOTICE SENT TO IB—
Jul 31, 2008FIMPFINAL DISPOSITION PROCESSED—
Jul 15, 2008FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Apr 15, 2008R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Jan 29, 2008PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Jan 9, 2008NPUBNOTICE OF PUBLICATION—
Dec 22, 2007PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
Dec 22, 2007ALIEASSIGNED TO LIE—
Nov 13, 2007CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Nov 13, 2007XAECEXAMINER'S AMENDMENT ENTERED—
Nov 13, 2007GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Nov 13, 2007GNEAEXAMINERS AMENDMENT E-MAILED—
Nov 13, 2007CNEAEXAMINERS AMENDMENT -WRITTEN—
Oct 11, 2007GNFNNOTIFICATION OF FINAL REFUSAL EMAILED—
Oct 11, 2007GNFRFINAL REFUSAL E-MAILEDA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Oct 11, 2007CNFRFINAL REFUSAL WRITTENA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Sep 19, 2007TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Sep 19, 2007CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Sep 19, 2007TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Sep 19, 2007ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Sep 19, 2007REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Apr 5, 2007RFNTREFUSAL PROCESSED BY IB—
Mar 20, 2007RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Mar 20, 2007RFRRREFUSAL PROCESSED BY MPU—
Mar 17, 2007RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Mar 16, 2007CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Mar 15, 2007DOCKASSIGNED TO EXAMINER—
Dec 15, 2006NWAPNEW APPLICATION ENTERED—
Dec 14, 2006REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance